Barclays
GSK icon

Barclays’s GSK GSK Stock Holding History

Barclays’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$21M Buy
380,397
+378,438
+19,318% +$20.5M 0.01% 1080
2025
Q4 		$96.1K Sell
1,959
-47,797
-96% -$2.23M ﹤0.01% 4591
2025
Q3 		$2.15M Buy
49,756
+44,977
+941% +$1.76M ﹤0.01% 2839
2025
Q2 		$184K Buy
4,779
+770
+19% +$29.4K ﹤0.01% 4332
2025
Q1 		$155K Sell
4,009
-45,619
-92% -$1.67M ﹤0.01% 4177
2024
Q4 		$1.68M Buy
49,628
+47,689
+2,459% +$1.72M ﹤0.01% 3034
2024
Q3 		$79.3K Sell
1,939
-97,527
-98% -$3.99M ﹤0.01% 4630
2024
Q2 		$3.83M Buy
99,466
+3,172
+3% +$133K ﹤0.01% 1698
2024
Q1 		$4.13M Buy
96,294
+90,220
+1,485% +$3.72M ﹤0.01% 1994
2023
Q4 		$225K Buy
6,074
+4,585
+308% +$165K ﹤0.01% 4362
2023
Q3 		$54K Buy
1,489
+263
+21% +$9.34K ﹤0.01% 3839
2023
Q2 		$43.7K Sell
1,226
-83,180
-99% -$2.98M ﹤0.01% 3900
2023
Q1 		$3M Buy
84,406
+11,855
+16% +$415K ﹤0.01% 1904
2022
Q4 		$2.55M Sell
72,551
-237,807
-77% -$7.92M ﹤0.01% 2092
2022
Q3 		$9.13M Buy
310,358
+308,981
+22,439% +$11.7M 0.01% 886
2022
Q2 		$74K Sell
1,377
-1,200
-47% -$66.2K ﹤0.01% 3893
2022
Q1 		$140K Sell
2,577
-5,117
-67% -$278K ﹤0.01% 3623
2021
Q4 		$424K Sell
7,694
-48,651
-86% -$2.53M ﹤0.01% 3275
2021
Q3 		$2.69M Sell
56,345
-902,350
-94% -$45.3M ﹤0.01% 2097
2021
Q2 		$47.7M Buy
958,695
+925,886
+2,822% +$44.5M 0.02% 539
2021
Q1 		$1.46M Sell
32,809
-4,875
-13% -$221K ﹤0.01% 2529
2020
Q4 		$1.73M Buy
37,684
+20,595
+121% +$946K ﹤0.01% 2347
2020
Q3 		$804K Buy
17,089
+5,063
+42% +$254K ﹤0.01% 2873
2020
Q2 		$613K Sell
12,026
-13,742
-53% -$705K ﹤0.01% 3173
2020
Q1 		$1.22M Sell
25,768
-135,461
-84% -$7.23M ﹤0.01% 2753
2019
Q4 		$9.47M Buy
161,229
+108,336
+205% +$6.03M 0.01% 1443
2019
Q3 		$2.82M Sell
52,893
-77,793
-60% -$4M ﹤0.01% 2458
2019
Q2 		$6.54M Buy
130,686
+95,275
+269% +$4.78M ﹤0.01% 1627
2019
Q1 		$1.85M Sell
35,411
-3,510
-9% -$175K ﹤0.01% 2660
2018
Q4 		$1.86M Buy
38,921
+5,878
+18% +$289K ﹤0.01% 2480
2018
Q3 		$1.66M Sell
33,043
-60,271
-65% -$3.06M ﹤0.01% 3099
2018
Q2 		$4.7M Buy
93,314
+37,103
+66% +$1.87M ﹤0.01% 1775
2018
Q1 		$2.75M Sell
56,211
-69,710
-55% -$3.25M ﹤0.01% 2155
2017
Q4 		$5.58M Buy
125,921
+66,953
+114% +$3.09M ﹤0.01% 1589
2017
Q3 		$2.99M Buy
58,968
+33,481
+131% +$1.7M ﹤0.01% 1962
2017
Q2 		$1.37M Buy
25,487
+4,055
+19% +$216K ﹤0.01% 2590
2017
Q1 		$1.13M Buy
21,432
+13,974
+187% +$709K ﹤0.01% 2635
2016
Q4 		$358K Buy
7,458
+1,144
+18% +$56.5K ﹤0.01% 3672
2016
Q3 		$341K Sell
6,314
-77,766
-92% -$4.26M ﹤0.01% 3546
2016
Q2 		$4.55M Buy
84,080
+22,829
+37% +$1.2M 0.01% 1379
2016
Q1 		$3.06M Sell
61,251
-15,904
-21% -$792K ﹤0.01% 1569
2015
Q4 		$3.86M Sell
77,155
-90,847
-54% -$4.63M ﹤0.01% 1497
2015
Q3 		$7.98M Sell
168,002
-753,809
-82% -$39.2M 0.01% 1064
2015
Q2 		$47.3M Sell
921,811
-3,365,043
-78% -$189M 0.05% 306
2015
Q1 		$246M Buy
4,286,854
+4,017,086
+1,489% +$230M 0.28% 45
2014
Q4 		$14.2M Sell
269,768
-59,915
-18% -$3.35M 0.01% 963
2014
Q3 		$18.6M Buy
329,683
+234,359
+246% +$14.4M 0.02% 757
2014
Q2 		$6.33M Buy
95,324
+8,620
+10% +$583K 0.01% 1529
2014
Q1 		$5.75M Buy
86,704
+4,029
+5% +$272K 0.01% 1596
2013
Q4 		$5.48M Sell
82,675
-29,163
-26% -$1.89M 0.01% 1753
2013
Q3 		$6.99M Sell
111,838
-11,218
-9% -$722K 0.01% 1425
2013
Q2 		$7.69M Buy
+123,056
New +$7.81M 0.01% 1286

Other funds holding GSK

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
JEST
JTC Employer Solutions Trustee St Helier, Jersey $1.2B AUM 37.55% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Barclays's GSK Position: Q1 2026 in Review

Barclays increased its GSK (GSK) stake by 19,318% in Q1 2026, buying an estimated $20.5M and bringing the position to 380,397 shares worth $21M. The position accounts for 0.01% of the portfolio, ranked #1080.

Barclays first reported a position in GSK in Q2 2013 and has held it in 52 quarters since. The position peaked at $246M in Q1 2015. 1,031 funds tracked by Wall St. Rank hold GSK as of Q1 2026.

  • Barclays held 380,397 shares of GSK worth $21M as of Q1 2026.
  • Barclays bought 378,438 GSK shares in Q1 2026, an estimated $20.5M.
  • GSK made up 0.01% of Barclays's portfolio in Q1 2026, its #1080 holding.
  • Barclays first reported a position in GSK in Q2 2013 and has held it in 52 quarters since.
  • Barclays's GSK position peaked at $246M in Q1 2015.
  • 1,031 funds tracked by Wall St. Rank held GSK as of Q1 2026.

Based on Barclays's 13F filing for Q1 2026, filed 15 May 2026.